Correction: Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized VLPs Induces Neutralizing Antibodies without Causing Enhancement of Dengue Virus Infection. Vaccines 2019, 7, 72

Vaccines (Feb 2020)

Affiliations

Gustavo Cabral-Miranda: The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK
Stephanie M. Lim: Artemis Bio-Support, Molengraaffsingel, 2629 Delft, The Netherlands
Mona O. Mohsen: The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK
Ilya V. Pobelov: Department of Chemistry and Biochemistry, University of Bern, 3010 Bern, Switzerland
Elisa S. Roesti: Immunology, RIA, Inselspital, University of Bern, 3010 Bern, Switzerland
Matthew D. Heath: Bencard Adjuvant Systems, Worthing BN14 8SA, UK
Murray A. Skinner: Bencard Adjuvant Systems, Worthing BN14 8SA, UK
Matthias F. Kramer: Bencard Adjuvant Systems, Worthing BN14 8SA, UK
Byron E.E Martina: Artemis Bio-Support, Molengraaffsingel, 2629 Delft, The Netherlands
Martin F. Bachmann: The Jenner Institute, Nuffield Department of Medicine, Centre for Cellular and Molecular Physiology (CCMP), University of Oxford, Oxford OX1 2JD, UK

Abstract

The authors wish to make the following correction to their paper [...]